Skip to content

Clinical study of exercise intervention for non-obese patients with polycystic ovary syndrome

Evaluation and mechanism of exercise intervention in polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097708
Enrollment
Unknown
Registered
2025-02-24
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Non-exercise intervention group:Usual treatment without exercise intervention.
Aerobic exercise intervention group:Mainly brisk walking, it is required to walk at a faster frequency, sweat without feeling excessively tired, and no obvious muscle soreness the next day, insist on
Resistance exercise intervention group:Strength training for the chest, legs, arms and abdomen, 3 days a week, 1 hour each time, for a total of 16 weeks (including 4 microcycles), each microcycle incr

Sponsors

West China Second University hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1.2003 Rotterdam Standard Diagnosis of PCOS; 2.Aged 20~38 years; 3.BMI <=25 kg/m^2; 4.Willing to participate in the clinical study.

Exclusion criteria

Exclusion criteria: 1.Recent use of drugs that may affect reproductive function (including estrogen, progesterone, testosterone, growth hormone, ovulation promoting drugs, etc.); 2.Combined with other hyperandrogen diseases (including androgen producing ovarian tumors, congenital adrenal hyperplasia, Cushing's syndrome, hyperprolactinemia, thyroid dysfunction); 3.Can not cooperate with the use of contraceptive measures (such as: condoms) during the exercise intervention, resulting in incomplete exercise cycle implementation; 4.Patients with serious heart, liver, lung, bone and joint, tumor and other diseases can not participate in the assessment; 5.Those who have cognitive dysfunction (MMSE < 17 points in simple mental state examination).

Design outcomes

Primary

MeasureTime frame
Menstrual frequency;

Secondary

MeasureTime frame
Improvement in sex hormone levels;Improvement in insulin resistance;Changes in body composition;Follicular condition;

Countries

China

Contacts

Public ContactChan Zhu

West China Second University hospital of Sichuan University

zc34534@scu.edu.cn+86 159 8280 3834

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 11, 2026